Targeting Autophagy in Cardiovascular Disease

Autophagy is an important pathway for breaking down proteins and damaged organelles and may play an important role in reducing cardiovascular diseases. Discover the latest research on Targeting Autophagy in Cardiovascular Disease here.

December 7, 2021

Role of Autophagy in Cardiovascular Disease and Aging.

Christos Koutouroushis, Oiendrila Sarkar
December 6, 2021
Open Access

Atheroprotective Effects and Molecular Mechanism of Berberine.

Frontiers in Molecular Biosciences
Lu XingHui-Ling Cao
December 4, 2021

Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19.

The Journal of Pathology
Lihui GuoDiederik van de Beek
December 4, 2021
Open Access

Endoplasmic Reticulum-Mitochondria Contacts: A Potential Therapy Target for Cardiovascular Remodeling-Associated Diseases.

Frontiers in Cell and Developmental Biology
Yu WangChao Li
December 4, 2021
Open Access

Targeting the Tumor Microenvironment: A Literature Review of the Novel Anti-Tumor Mechanism of Statins.

Frontiers in Oncology
Peng-Fei ZhuLiu Yang
November 29, 2021

[Neuroprotective mechanism of autophagy in bradykinin postconditioning after cardiac arrest in rats].

Zhonghua wei zhong bing ji jiu yi xue
Yujia LinShirong Lin
November 29, 2021

Role of AMPK mediated pathways in autophagy and aging.

Yuchen GeXiaobo Wang
November 28, 2021

Spermidine Supplementation Protects the Liver Endothelium from Liver Damage in Mice.

Genís CampreciósVirginia Hernández-Gea
November 28, 2021

Mitochondrial Quality Control in Cardiac-Conditioning Strategies against Ischemia-Reperfusion Injury.

Wylly Ramsés García-NiñoAlejandro Silva-Palacios
November 28, 2021
Open Access

Bad Smells and Broken DNA: A Tale of Sulfur-Nucleic Acid Cooperation.

Rodney E ShackelfordChristopher G Kevil
November 26, 2021
Open Access

Recent Research Progress (2015-2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA.

Frontiers in Pharmacology
Chenhui ZhongHong Yao
November 26, 2021
Open Access

Cardiomyocytes Cellular Phenotypes After Myocardial Infarction.

Frontiers in Cardiovascular Medicine
Alessandra Maria Lodrini, Marie-José Goumans

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

© 2021 Meta ULC. All rights reserved